Comparing the Big 3, Semaglutide, Tirzepatide and Retatrutide : r Mounjaro Zepbound Outperforms CagriSema in Head to Head Phase III Obesity Trial Semaglutide + Cagrilintide Combo Medical Weight Loss in Walnut Creek Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination CagriSema Dual Pathway Metabolic Signaling Compound CagriSema combines two investigational molecules Cagrilintide (amylin analogue) and Semaglutide (GLP 1 receptor agonist), designed to influence key metabolic and appetite regulating pathways. Current Cagrilintide Semaglutide combo Improves Weight Loss and Glycemic Control in T2DM, finds trial